Qsam Financial Statements From 2010 to 2024

QSAMDelisted Stock  USD 4.49  0.05  1.13%   
Qsam Biosciences financial statements provide useful quarterly and yearly information to potential Qsam Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Qsam Biosciences financial statements helps investors assess Qsam Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Qsam Biosciences' valuation are summarized below:
Qsam Biosciences does not presently have any trending fundamental ratios for analysis.
Check Qsam Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Qsam Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Qsam financial statements analysis is a perfect complement when working with Qsam Biosciences Valuation or Volatility modules.
  
This module can also supplement various Qsam Biosciences Technical models . Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.

Qsam Biosciences OTC Stock Return On Equity Analysis

Qsam Biosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Qsam Biosciences Return On Equity

    
  -33.77  
Most of Qsam Biosciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Qsam Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Qsam Biosciences has a Return On Equity of -33.7707. This is 40.89% higher than that of the Biotechnology sector and 7.38% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

Qsam Biosciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Qsam Biosciences's current stock value. Our valuation model uses many indicators to compare Qsam Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Qsam Biosciences competition to find correlations between indicators driving Qsam Biosciences's intrinsic value. More Info.
Qsam Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Qsam Biosciences' earnings, one of the primary drivers of an investment's value.

About Qsam Biosciences Financial Statements

Qsam Biosciences investors utilize fundamental indicators, such as revenue or net income, to predict how Qsam OTC Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas. Qsam Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.
Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in Qsam OTC Stock

If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum